Your browser doesn't support javascript.
loading
Quality-of-Life Outcomes and Toxic Effects Among Patients With Cancers of the Uterus Treated With Stereotactic Pelvic Adjuvant Radiation Therapy: The SPARTACUS Phase 1/2 Nonrandomized Controlled Trial.
Leung, Eric; Gladwish, Adam P; Davidson, Melanie; Taggar, Amandeep; Velker, Vikram; Barnes, Elizabeth; Mendez, Lucas; Donovan, Elysia; Gien, Lilian T; Covens, Allan; Vicus, Danielle; Kupets, Rachel; MacKay, Helen; Han, Kathy; Cheung, Patrick; Zhang, Liying; Loblaw, Andrew; D'Souza, David P.
Affiliation
  • Leung E; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
  • Gladwish AP; Department of Radiation Oncology, Royal Victoria Hospital, University of Toronto, Barrie, Ontario, Canada.
  • Davidson M; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
  • Taggar A; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
  • Velker V; Division of Radiation Oncology, Department of Oncology, London Health Sciences Centre, Western University, London, Ontario, Canada.
  • Barnes E; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
  • Mendez L; Division of Radiation Oncology, Department of Oncology, London Health Sciences Centre, Western University, London, Ontario, Canada.
  • Donovan E; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
  • Gien LT; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Sunnybrook Health Sciences Centre, Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
  • Covens A; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Sunnybrook Health Sciences Centre, Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
  • Vicus D; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Sunnybrook Health Sciences Centre, Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
  • Kupets R; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Sunnybrook Health Sciences Centre, Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
  • MacKay H; Divison of Medical Oncology and Hematology, Sunnybrook Health Sciences Centre, Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
  • Han K; Department of Radiation Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
  • Cheung P; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
  • Zhang L; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
  • Loblaw A; Department of Radiation Oncology, Sunnybrook Health Sciences Centre, Odette Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
  • D'Souza DP; Division of Radiation Oncology, Department of Oncology, London Health Sciences Centre, Western University, London, Ontario, Canada.
JAMA Oncol ; 8(6): 1-9, 2022 06 01.
Article de En | MEDLINE | ID: mdl-35420695

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Qualité de vie / Tumeurs de l'utérus Type d'étude: Clinical_trials / Etiology_studies / Prognostic_studies Aspects: Patient_preference Limites: Aged / Female / Humans Pays/Région comme sujet: America do norte Langue: En Journal: JAMA Oncol Année: 2022 Type de document: Article Pays d'affiliation: Canada

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Qualité de vie / Tumeurs de l'utérus Type d'étude: Clinical_trials / Etiology_studies / Prognostic_studies Aspects: Patient_preference Limites: Aged / Female / Humans Pays/Région comme sujet: America do norte Langue: En Journal: JAMA Oncol Année: 2022 Type de document: Article Pays d'affiliation: Canada